3DPrint.com July 19, 2024
Joris Peels

3D printing software and service pioneer Materialise (Nasdaq: MTLS) has bought FEops, a cardiac care software package developer that uses AI to simulate and predict outcomes of cardiac procedures. Specifically, FEops deals with transcatheter structural heart devices. Structural heart diseases can include congenital conditions or issues like coronary artery disease and hypertrophic cardiomyopathy, a thickening of heart tissue leading to less blood being pumped. When devices are used to ameliorate these conditions, they generally have to be customized to work well. In the case of heart valves, treatment could involve putting a balloon inside to open the area or major surgery to replace the valve by opening up the chest. A newer set of procedures includes TAVR, also called Transcatheter...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: 3D Printing, AI (Artificial Intelligence), Mergers & Acquisitions / JV, Technology, Trends
Related Articles:
How 3D Printing Impacts Radiology
Ricoh’s 3D Printing Improves Surgical Accuracy and Safety One Layer at a Time
3D-printed hydrogel enables continuous drug delivery via contact lens
Improved 3D printed blood vessels thanks to bioink with DNA
DNA-based bioink technology enables precise 3D-printing of blood vessels

Share This Article